We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Spindle Replacement Therapy Prevents Transmission of Inherited Mitochondrial Diseases

By LabMedica International staff writers
Posted on 09 Sep 2009
In the future, inherited diseases caused by mutations in mitochondrial DNA (mtDNA) may be avoided by the use of a novel gene therapy technique that transfers a defective egg's genome into an enucleated egg with healthy mtDNA.

Approximately 150 diseases, including certain forms of cancer, diabetes, infertility, myopathies, and neurodegenerative diseases, are caused by defective mtDNA; and approximately one out of every 200 children is born with mitochondrial mutations.

To correct this situation, investigators from the Oregon Health & Science University (Beaverton, USA) worked with monkeys as a model of human inherited mitochondrial disease. More...
They reported in the August 26, 2009, online edition of the journal Nature that by employing a technique called spindle replacement they could remove the genetic material from an egg with mutated mtDNA and transfer it to an enucleated egg with healthy mtDNA.

The experiment was performed using eggs from two different monkeys. After transfer of the genetic material, the reconstructed eggs with the mitochondrial replacement were capable of supporting normal fertilization, embryo development, and produced healthy offspring. DNA screening studies of the baby monkeys that developed from the reconstructed eggs showed that they were genetically the offspring of the egg donor, but that their mitochondria were from the enucleated egg. No mtDNA from the donor egg could be detected in the offspring.

"In theory, this research has demonstrated that it is possible to use this therapy in mothers carrying mitochondrial DNA diseases so that we can prevent those diseases from being passed on to their offspring,” said senior author Dr. Shoukhrat Mitalipov, assistant scientist in reproductive biology at the Oregon Health and Science University. "We believe that with the proper governmental approvals, our work can rapidly be translated into clinical trials for humans, and, eventually, approved therapies.”

Related Links:

Oregon Health & Science University




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.